Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Diverse immunological and hematological effects of interleukin 7: implications for clinical application Komschlies KL; Grzegorzewski KJ; Wiltrout RHJ Leukoc Biol 1995[Dec]; 58 (6): 623-33Interleukin-7 (IL-7) was originally discovered to be a pre-B cell growth factor. Soon thereafter, a broader role for IL-7 in leukocyte development and function began to be identified. IL-7 now has been shown to be a critical cytokine for normal T and B lymphopoiesis and a mobilizer of pluripotent stem cells and myeloid progenitors. IL-7 has been demonstrated to enhance T cell function and induce cytokine expression in monocytes. Preclinical studies have already found that IL-7 could accelerate murine lymphocyte regeneration following chemotherapy and bone marrow transplantation, induce antitumor effects in mice, and expand anti-HIV-specific human T cells. Thus it is essential that further preclinical and clinical research be performed to evaluate IL-7 as a potential therapy for leukopenia, bone marrow/stem cell transplantation, cancer, and HIV/AIDS.|Acquired Immunodeficiency Syndrome/therapy[MESH]|Animals[MESH]|Antigens, CD/physiology[MESH]|Cell Differentiation[MESH]|Hematopoiesis[MESH]|Humans[MESH]|Interleukin-7/*physiology/therapeutic use[MESH]|Mice[MESH]|Neoplasms/therapy[MESH]|Receptors, Interleukin-7[MESH]|Receptors, Interleukin/physiology[MESH]|T-Lymphocytes/physiology[MESH] |
